A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy with the IRX-2 Regimen in Patients with Newly Diagnosed Stage II, III or IVA Squamous Cell Carcinoma of the Oral Cavity.

UCI-17-33
NCT02609386
Cancer - Lip, Oral Cavity and Pharynx
Samuel Ejadi
Open
Treatment
Cyclophosphamide, Cytoxan, IRX‐2, Indomethacin, Omeprazole, Prilosec, Zinc-Containing Multivitamins
II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.